PDCD1 and neoplasm: We recorded tumor volume and mice body weight every 2 d, and the results indicated that zosuquidar exhibited obvious tumor growth‐inhibitive effects without affecting body weight, similar to PD‐1 mAb (Figure 2B and Figure S2C, Supporting Information).